feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    UID:
    almafu_9959000169102883
    Format: 1 online resource (XVII, 341 p. 113 illus., 10 illus. in color.)
    Edition: 1st ed. 2013.
    ISBN: 1-62703-173-1
    Series Statement: Neuromethods, 75
    Content: Since its first application, microdialysis has become incredibly popular to study brain function and has been applied with success in different fields from psychopharmacology, neurobiology, and physiology in animals and also humans. Microdialysis Techniques in Neuroscience focuses on the practical aspects of microdialysis in animal and human, highlighting current technical limitations and providing a vision of what is yet to come for the determination of the most disparate compounds in the brain. The book’s contents range from new techniques for detection and quantifying the release of several different neurotransmitters in vitro and in vivo, even in freely moving animals, to sophisticated use of reverse dialysis and the application of microdialysis in pharmacokinetic studies. Each of the sixteen chapters, in fitting with the spirit of the Neuromethods series, contain an introduction that gives a broad overview of a focused topic, followed by an extensive protocol on how the experiments are performed along with invaluable practical advice.   Detailed and authoritative, Microdialysis Techniques in Neuroscience will be a valuable reference for students, neuroscientists, and physicians for the use of microdialysis in the study of brain functions and its clinical applications.
    Note: Bibliographic Level Mode of Issuance: Monograph , Cerebral Microdialysis: Research Technique or Clinical Tool? -- In Vivo Microdialysis to Study Striatal Dopaminergic Neurodegeneration -- Application of Reverse Microdialysis in Neuropharmacological Studies -- Microdialysis and Advances for Sampling Synaptic and Extrasynaptic Pools -- In Vivo Microdialysis for Measurement of Oxidative Metabolism in the Living Brain -- Quantitative In Vivo Microdialysis in Pharmacokinetic Studies -- Combination of In Vivo Microdialysis with Selective Electrochemical Detection for Online Continuously Monitoring Brain Chemistry -- Application of Spinal Microdialysis in Freely Moving Rats -- Monitoring Extracellular Monoamines with In Vivo Microdialysis in Awake Rats: A Practical Approach -- Intracerebral Human Microdialysis in Parkinson’s Disease -- Monitoring Extracellular Amino Acid Neurotransmitters and hROS by In Vivo Microdialysis in Rats: A Practical Approach -- Measurement of Neuropeptides in Dialysate by LC-MS -- Achieving High Temporal Resolution for In Vivo Measurements by Microdialysis -- Indirect Analysis of Nitric Oxide and Quantitation of Selective Nitric Oxide Synthase Inhibitors in Microdialysate Samples -- Determination of Histamine in Microdialysis Samples from the Rodent Brain by Column Liquid Chromatography -- Intracerebral Microdialysis in the Study of Limbic Seizure Mechanisms and Antiepileptic Drug Action Using Freely Moving Rats. , English
    Additional Edition: ISBN 1-62703-172-3
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    [Hauppauge] N.Y. :Nova Science Publishers, Inc.,
    UID:
    edocfu_9959236401602883
    Format: 1 online resource (295 p.)
    Edition: 1st ed.
    ISBN: 1-62081-344-0
    Series Statement: Substance abuse assessment, interventions and treatment
    Note: Description based upon print version of record. , Intro -- Contents -- Preface -- Chapter 1 -- Nicotine Addiction and Treatment: Recent Advances -- Abstract -- Introduction -- Nicotine Addiction -- Involvement of Nicotinic Acetylcholine Receptors -- Involvement of Neurotransmitters -- Dopamine -- Glutamate -- GABA -- Endocanabinoid System -- Endogenous Opioid System -- 5-HT -- Norepinephrine -- Involvement of Monoamine Oxidase -- Neuronal Function -- Health Effects -- Prevention -- Therapeutic Option -- Nicotine Therapy -- Non-Nicotine Therapy -- Bupropion -- Varenicline -- Nicotine Vaccine -- Research Advances -- Conclusion -- Acknowledgment -- References -- Chapter 2 -- Serotonin-Dopamine Interaction in Nicotine Addiction: Focus on 5-HT2C Receptors -- Abstract -- Introduction -- Dopamine Systems -- Serotonin Systems -- 5-HT Receptors Localization -- The 5-HT2 Receptor Family -- Effects of Nicotine on Central Dopaminergic Function -- Effects of Nicotine on Central Serotonergic Function -- Serotonin 2C (5-HT2C) and Nicotine Rewarding Properties -- Serotonergic Drug Treatment for Smoking Cessation -- Conclusion -- Acknowledgments -- References -- Chapter 3 -- Defining the Role of the Hippocampus in Nicotine Addiction -- Abstract -- Introduction -- Canonical View of Reward and Addiction -- Connectivity between the Hippocampus and the Reward Circuitry -- Nicotine-Associated Contexts and Cues -- Hippocampal Nicotinic Acetylcholine Receptors, Plasticity and Addiction -- Hippocampus, Stress and Withdrawal -- Towards a Hippocampus Model for Nicotine Addiction -- Acknowledgments -- References -- Chapter 4 -- Nicotine, Neurodegeneration, and Neuroprotection in Neuropsychiatric Disorders -- Abstract -- Introduction -- Nicotine Neuroprotection -- in Neurodegenerative Diseases -- Nicotine and Alzheimer's Disease -- Nicotine Influence on Cognitive Impairment. , Nicotine, the Cholinergic System and Alzheimer's Disease -- Nicotine and Parkinson's Disease -- Nicotine and the Pathology of Parkinson's Disease -- Nicotine and other Memory Disorders -- Nicotine Neuroprotection in Neural Injury -- Nicotine Neuroprotection in Psychiatric Disorders -- Nicotine and Schizophrenia -- Nicotinic Acetylcholine Receptors in Schizophrenia -- Auditory Evoked Potential Inhibition Deficits in Schizophrenia -- Smooth Pursuit Eye Movement Deficits in Schizophrenia -- Prepulse Inhibition of Startle Response Deficits in Schizophrenia -- Neuropsychological Impairments in Schizophrenia -- Pharmacologic Interventions Targeting the Nicotinic Acetylcholine System -- Nicotine and Bipolar Mood Disorder -- Symptom Progression in Smoking Bipolar Patients -- Genetics of Bipolar Disorder and Nicotinic Acetylcholine Receptors -- Conclusion -- References -- Chapter 5 -- Stress as a Risk Factor for Transition to Heightened Nicotine Intake: Evidence from a Rat Model of Nicotine Self-Administration -- Abstract -- Introduction -- Materials and Methods -- Subjects -- Self-Administration Apparatus -- Food Training -- Surgery -- Nicotine Self-Administration -- Effect of Pharmacological Stress on Nicotine Intake -- Statistical Analyses -- Results -- Nicotine Self-Administration in the LNT and HNT Rats -- Effect of Yohimbine on Nicotine Self-Administration in the LNT Rats -- Effect of Yohimbine on Nicotine Self-Administration in the HNT Rats -- Effect of Yohimbine in Saline-Trained Rats -- Discussion -- Conclusion -- Acknowledgments -- References -- Chapter 6 -- Smoking, Nicotine and Depression: A Review -- Abstract -- Introduction -- General Aspects of Nicotine -- Pharmacology -- Metabolism -- Nicotinic Receptors -- General Characteristics of Depression -- Smoking, Nicotine and Depression -- Epidemiology. , Hypothesis on the Increase in Indexes of Smoking among Patients with Major Depression -- Interaction Mechanisms of Nicotine in Depressive Disorders -- Conclusion -- References -- Chapter 7 -- New Psychological Approaches in Nicotine Addiction -- Abstract -- Introduction -- Prevention -- Cessation -- Relapse Prevention -- Conclusion -- References -- Chapter 8 -- Cognitive Consequences of Adolescent and Adult Nicotine Exposure: Utility of Animal Models -- Abstract -- Introduction -- Benefits of Rat Models for Studying Developmental Processes in Drug Addiction -- The Utility of the Rat as an Experimental Model of Adolescent Nicotine Exposure -- Hallmarks of Adolescence in the Rat -- Effects of Adult Nicotine Exposure on Cognition in Animals -- Effects of Adolescent Nicotine Exposure on Neural Development and Cognition in Animals -- Conclusion -- Acknowledgments -- References -- Chapter 9 -- Psychosocial Risk Factors for Smoking and Nicotine Dependence: Implications for Prevention and Treatment -- Abstract -- Introduction -- Purpose of Study -- Background -- Properties and Effects of Nicotine -- Mechanism of Nicotine Dependence -- Theoretical Framework -- Neurobiological Model -- Associative Learning Model -- Depression -- Smoking Expectancies -- The Personality Trait of Neuroticism -- Childhood Adversity -- Methodology of the Study -- Sample -- Measures -- Data Collection -- Results -- Conclusion -- Implications for Treatment: Assessment -- Nicotine Replacement Therapy -- Anti-Depressant Therapy -- Varencline -- Strategies to Motivate Change and Prevent Relapse -- Case Study -- Further Recommendations -- References -- Chapter 10 -- Effects Associated with the Structure of Adsorbents on the Degrees to Which Nicotine, Tar and CO are Reduced in Tobacco Smoke -- Abstract -- Introduction. , Novel Materials Efficient For Reducing Nicotine, Tar and CO Contents -- Preparation of Cigarette Samples -- Composite Filter -- Chemical Composition of the Mainstream Tobacco Smoke -- Efficiency of the Sorption Removal -- The Factor of Selectivity -- Specific Sorption Capacity of Investigated Material -- The Effects of a Hydrophilic Type Zeolite on the Degree of Reduction of Nicotine, Tar and CO in Tobacco Smoke -- The Effects Associated with the Degree of Hydrophobicity of the Zeolite on the Degree of Reduction of Tobacco Smoke Components -- The Effects Associated With the Type of Amorphous Material on the Degree of Reduction of Tobacco Smoke Components -- Conclusion -- Acknowledgment -- References -- Chapter 11 -- Kinetics of Nicotine Bonding Onto and Release from Poly (Acrylic -co-Methacrylic Acid) Hydrogel -- Abstract -- Introduction -- Poly(Acrylic Acid-Cco-Methacrylic Acid) Hydrogel Synthesis -- Nicotine Bonding and Release -- Poly(Acrylic Acid-co-methacrylic Acid) Hydrogel Synthesis -- Nicotine Bonding -- Nicotine Release -- Isothermal Kinetics of Nicotine Bonding and Release -- Models of Kinetic Nicotine Bonding to the Hydrogel -- The Kinetics Model of Nicotine Release from the Hydrogel -- Conclusion -- Acknowledgment -- References -- Index -- Blank Page. , English
    Additional Edition: ISBN 1-62081-290-8
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    [Hauppauge] N.Y. :Nova Science Publishers, Inc.,
    UID:
    almahu_9948321337302882
    Format: x, 283 p. : , ill. (some col.).
    Edition: Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
    Series Statement: Substance abuse assessment, interventions and treatment
    Language: English
    Keywords: Electronic books.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    almahu_9949419365002882
    Format: XII, 560 p. , online resource.
    Edition: 1st ed. 2011.
    ISBN: 9781607619413
    Series Statement: The Receptors, 22
    Content: Research of 5-HT2c receptors stretches back twenty-five years, and while much of it has been productive, the past decade of research has been extraordinary in terms of both amount produced and insights gained. It is hardly surprising that 5-HT2c receptor research has grown so fruitful, given that it is a prominent central serotonin receptor subtype widely expressed within the central and the peripheral nervous system and is thought to play a major role in the regulation of numerous behaviors. It has further been shown by experimental and clinical observation that it may represent a possible therapeutic target for the development of drugs for a range of central nervous system disorders. The time, therefore, is more than appropriate to offer the first ever overview of the research of 5-HT2c receptors. Part of the popular and important series, "The Receptors," The 5-HT2c Receptor provides a thorough update of the functional status of the 5-HT2c receptor. It covers the molecular, cellular, anatomical, biochemical and behavioral aspects of this receptor so as to highlight its distinctive regulatory properties and the emerging functional significance of constitutive activity and RNA-editing in vivo. In addition, the book investigates the receptors' therapeutic potential in a range of different diseases, treated individually in separate chapters, including depression, drug abuse, schizophrenia, eating disorders, Parkinson's disease, Prader-Willi Syndrome, Alzheimer's disease and epilepsy. While not exhaustive, this text is a vital tool in understanding the past and inspiring the future of interdisciplinary research on the 5-HT2c receptor.
    Note: The making of the 5-HT2C receptor -- Serotonin 5-HT2C receptors: chemical neuronatomy in the mammalian brain -- The medicinal chemistry of 5-HT2C receptor ligands -- Insights into 5-HT2C receptor function gained from transgenic mouse models -- Serotonin 5-HT2C receptor signal transduction -- Homology modeling of 5-HT2C receptors -- 5-HT2C receptor dimerization -- RNA editing of 5-HT2C receptor and neuropsychiatric diseases -- Serotonergic control of adult neurogenesis: focus on 5-HT2C receptors -- The constitutive activity of 5-HT2C receptors as an additional modality of interaction of the serotonergic system -- The 5-HT2C receptor subtype controls central dopaminergic systems: evidence from electrophysiological and neurochemical studies -- The role of serotonin-2C receptors in the pathophysiology of depression -- 5-HT2C receptors and suicidal behaviour -- The 5-HT2C receptor as a target for schizophrenia -- Serotonin and reward-related behaviour: focus on 5-HT2C receptors -- Tat-3L4F: a novel peptide for treating drug addiction by disrupting interaction between PTEN and 5-HT2C receptor -- The role of serotonin in eating behaviour: focus on 5-HT2C receptors -- Physiological and pathophysiological aspects of 5-HT2C receptors in basal ganglia -- Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment -- The role of 5-HT2A/2C receptors in sleep and waking -- Role of alternative splicing of the 5-HT2C in the Prader-Willi syndrome -- The role of 5-HT2C receptor in epilepsy -- The role of serotonin on attentional processes and executive functioning: focus on 5-HT2C receptors -- 5-HT2C receptors in learning -- The role of 5-HT2C polymorphisms in behavioural and psychological symptoms of alzheimer's disease -- Ocular hypotension: involvement of serotonergic 5-HT2C receptors.
    In: Springer Nature eBook
    Additional Edition: Printed edition: ISBN 9781607619406
    Additional Edition: Printed edition: ISBN 9781617797200
    Additional Edition: Printed edition: ISBN 9781607619420
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Totowa, NJ : Springer Science+Business Media, LLC
    UID:
    gbv_1650616805
    Format: Online-Ressource (XI, 557p. 70 illus., 25 illus. in color, digital)
    Edition: 1
    ISBN: 9781607619413
    Series Statement: The Receptors 22
    Content: Research of 5-HT2c receptors stretches back twenty-five years, and while much of it has been productive, the past decade of research has been extraordinary in terms of both amount produced and insights gained. It is hardly surprising that 5-HT2c receptor research has grown so fruitful, given that it is a prominent central serotonin receptor subtype widely expressed within the central and the peripheral nervous system and is thought to play a major role in the regulation of numerous behaviors. It has further been shown by experimental and clinical observation that it may represent a possible therapeutic target for the development of drugs for a range of central nervous system disorders. The time, therefore, is more than appropriate to offer the first ever overview of the research of 5-HT2c receptors. Part of the popular and important series, 'The Receptors,' The 5-HT2c Receptor provides a thorough update of the functional status of the 5-HT2c receptor. It covers the molecular, cellular, anatomical, biochemical and behavioral aspects of this receptor so as to highlight its distinctive regulatory properties and the emerging functional significance of constitutive activity and RNA-editing in vivo. In addition, the book investigates the receptors' therapeutic potential in a range of different diseases, treated individually in separate chapters, including depression, drug abuse, schizophrenia, eating disorders, Parkinson's disease, Prader-Willi Syndrome, Alzheimer's disease and epilepsy. While not exhaustive, this text is a vital tool in understanding the past and inspiring the future of interdisciplinary research on the 5-HT2c receptor.
    Note: Description based upon print version of record , 5-HT2C Receptors in the Pathophysiologyof CNS Disease; Preface; Contents; Chapter 1: The Making of the 5-HT2C Receptor; Chapter 2: Serotonin 5-HT2C Receptors: Chemical Neuronatomy in the Mammalian Brain; Chapter 3: The Medicinal Chemistry of 5-HT2CReceptor Ligands; Chapter 4: Insights into 5-HT2C Receptor Function Gained from Transgenic Mouse Models; Chapter 5: Serotonin 5-HT2C Receptor Signal Transduction; Chapter 6: Homology Modeling of 5-HT2C Receptors; Chapter 7: 5-HT2C Receptor Dimerization; Chapter 8: RNA Editing of 5-HT2C Receptor and Neuropsychiatric Diseases , Chapter 9: Serotonergic Control of Adult Neurogenesis: Focus on 5-HT2C ReceptorsChapter 10: The Constitutive Activity of 5-HT2C Receptors as an Additional Modality of Interactionof the Serotonergic System; Chapter 11: The 5-HT2C Receptor Subtype Controls Central Dopaminergic Systems: Evidence from Electrophysiological and Neuroch; Chapter 12: The Role of 5-HT2C Receptors in the Pathophysiology and Treatment of Depression; Chapter 13: 5-HT2C Receptors and Suicidal Behavior; Chapter 14: The 5-HT2C Receptor as a Target for Schizophrenia , Chapter 15: Serotonin and Reward-Related Behavior: Focus on 5-HT2C ReceptorsChapter 16: Tat-3L4F: A Novel Peptide for Treating Drug Addiction by Disrupting Interaction Between PTEN and 5-HT2C Receptor; Chapter 17: The Role of Serotonin in Eating Behavior: Focus on 5-HT2C Receptors; Chapter 18: Physiological and Pathophysiological Aspects of 5-HT2c Receptors in Basal Ganglia; Chapter 19: Modeling Tardive Dyskinesia: Predictive 5-HT2C Receptor Antagonist Treatment; Chapter 20: The Role of 5-HT2A/2C Receptors in Sleep and Waking , Chapter 21: Role of Alternative Splicing of the 5-HT2C Receptor in the Prader-Willi SyndromeChapter 22: The Role of 5-HT2C Receptor in Epilepsy; Chapter 23: The Role of Serotonin on Attentional Processes and Executive Functioning: Focus on 5-HT2C Receptors; Chapter 24: 5-HT2C Receptors in Learning; Chapter 25: The Role of 5-HT2C Polymorphisms in Behavioral and Psychological Symptoms of Alzheimer Disease; Chapter 26: Ocular Hypotension: Involvement of Serotonergic 5-HT2 Receptors; Index;
    Additional Edition: ISBN 9781607619406
    Additional Edition: Buchausg. u.d.T. ISBN 978-1-607-61940-6
    Language: English
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    New York, NY : Springer New York
    UID:
    gbv_1659296854
    Format: Online-Ressource (IX, 295 p. 34 illus., 18 illus. in color, online resource)
    ISBN: 9781493914265
    Series Statement: The Receptors 27
    Content: GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABAA and GABAB receptors. Recently, a novel form of GABAA receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABAA receptors underlie classical "phasic" GABAA receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABAA receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABAA receptors are composed of receptor subunits that convey biophysical properties ideally suited to the ge
    Content: GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABAA and GABAB receptors. Recently, a novel form of GABAA receptor-mediated inhibition, termed “tonic” inhibition, has been described. Whereas synaptic GABAA receptors underlie classical “phasic” GABAA receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABAA receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABAA receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This book highlights ongoing work examining the properties of recombinant and native extrasynaptic GABAA receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABAA receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes
    Note: Includes index , A brief introduction to extrasynaptic GABAA receptors and ‘tonic’ GABAA receptor mediated inhibition in physiology and diseaseExtrasynaptic GABAA receptors: subunit composition, distribution, and regulation -- Biophysical properties of recombinant 2- AND δ- subunit containing GABAA receptors -- The pharmacology of extrasynaptic GABAA receptors -- Neurosteroids and extrasynaptic GABAA receptors -- Sources of GABA that activate extrasynaptic GABAA receptors -- Modulation of Extrasynaptic GABAA Receptors by G-protein-coupled Receptors -- Extrasynaptic GABAA receptors and tonic inhibition in spinal cord -- The role of peri-synaptic GABA receptors after stroke -- The role of extrasynaptic GABAA receptors in focal epilepsy -- Gain-of-Function of Thalamic Extrasynaptic GABA-A Receptors in Typical Absence Seizures -- GABAergic control of the hypothalamic-pituitary-adrenal (HPA) axis: role of extrasynaptic GABAA receptors -- Tonic GABAA receptor mediated inhibition in Fragile-X Syndrome: A cause of dysfunction or a pathway for a cure?.
    Additional Edition: ISBN 9781493914258
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-149-391-425-8
    Language: English
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages